Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

How does the NHS weigh the costs of HIV preventing drugs?

In August, the High Court ruled that NHS England can fund the use of PrEP – effective but very expensive drugs that prevent HIV infection. But with the NHS appealing that decision, it is unclear whether PrEP will ever be commissioned. Abi Millar explores whether anything could be done to make the drug more cost-efficient.

Go Top